Zai Lab Limited (NASDAQ:ZLAB) is one of the 10 biotech stocks screaming a buy. On June 17, the company delivered positive trial results from a preclinical study of ZL-1503, a promising IL-13/IL ...

SHANGHAI & CAMBRIDGE, Mass. & BAAR, Switzerland, May 31, 2025--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) and Novocure (NASDAQ: NVCR) announced that results from the Phase 3 PANOVA-3 trial of ...

SHANGHAI & CAMBRIDGE, Mass., June 02, 2025--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that updated data from an ongoing, global Phase 1a/1b clinical trial (NCT06179069) evaluating ...

Zai Lab Limited (NASDAQ:ZLAB) and NovoCure Limited (NASDAQ:NVCR) revealed landmark results from the Phase 3 PANOVA-3 trial at the 2025 ASCO Annual Meeting, marking the first therapy to show ...

Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Anti-Tumor Activity and Safety in Patients with Extensive-Stage Small Cell Lung Cancer at 2025 ASCO ...

Zai Lab Media: Shaun Maccoun / Xiaoyu Chen +1 (857) 270-8854 / +86 185 0015 5011 [email protected] / [email protected] Novocure Investors: Ingrid Goldberg ...

Zai Bennett, CEO and chief creative officer at BBC Studios Productions, is set to discuss his creative vision across an international portfolio spanning scripted, unscripted, global productions, kids ...

Zai Lab Limited (NASDAQ:ZLAB) is one of the 10 biotech stocks screaming a buy. On June 17, the company delivered positive trial results from a preclinical study of ZL-1503, a promising IL-13/IL ...

A high-level overview of Zai Lab Limited (ZLAB) stock. View (ZLAB) real-time stock price, chart, news, analysis, analyst reviews and more.

BIÑAN CITY — The city government of Biñan was recognized anew for its exemplary financial management after receiving an Unmodified Opinion, the highest audit rating from the Commission on Audit (COA) ...

Zai Lab is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing innovative ...